Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRoca, Neus
dc.contributor.authorJatem-Escalante, Elias
dc.contributor.authorMartin, Maria Luisa
dc.contributor.authorMuñoz López, Marina
dc.contributor.authorMolina, Maria
dc.contributor.authorMartínez, Cristina
dc.date.accessioned2021-07-15T12:15:06Z
dc.date.available2021-07-15T12:15:06Z
dc.date.copyright2020
dc.date.issued2020-01-17
dc.identifier.citationRoca N, Jatem E, Martín ML, Muñoz M, Molina M, Martínez C, et al. Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome. Clin Kidney J. 2020 Jan 17;14(2):543-549.
dc.identifier.issn2048-8513
dc.identifier.urihttp://hdl.handle.net/11351/6170
dc.descriptionBiomarcadores; Activación endotelial; Síndrome nefrótico
dc.descriptionBiomarkers; Endothelial activation; Nephrotic syndrome
dc.description.abstractBackground Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR constitutes a predictor of vascular disease and has been associated with endothelial dysfunction, we hypothesized that suPAR levels are related to endothelial activation or dysfunction in INS patients. The aims of this study were to evaluate the relationship between serum concentrations of endothelial biomarkers and suPAR in patients with different histological patterns of INS and healthy controls, and to determine the demographic, clinical and biochemical characteristics of INS patients that influence suPAR serum levels. Methods This observational, cross-sectional study included patients with INS, diagnosed with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS) or membranous nephropathy (MN) by renal biopsy. Patient demographic, clinical and biochemical characteristics were recorded and blood samples were obtained at the time of diagnosis. Measurements of suPAR and endothelial molecules via serum levels were performed using Enzyme-Linked ImmunoSorbent Assay kits. Results Patients with nephrotic syndrome (n = 152) caused by FSGS, MCD or MN had increased circulating levels of endothelial markers. suPAR levels positively correlated with age and the serum levels of almost all endothelial markers. Generally, endothelial cell molecules positively correlated with each other. suPAR levels were not associated with the histopathological pattern of INS. Conclusions In patients with INS secondary to FSGS, MCD and NM, circulating levels of suPAR are independent of the primary renal disease, and significantly associated with age, glomerular filtration rate and the levels of various endothelial markers.
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofseriesClinical Kidney Journal;14(2)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectRonyons - Malalties
dc.subjectActivadors plasminògens
dc.subject.meshNephrotic Syndrome
dc.subject.meshReceptors, Urokinase Plasminogen Activator
dc.titleRelationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/ckj/sfz173
dc.subject.decssíndrome nefrótico
dc.subject.decsreceptores del activador del plasminógeno de tipo urocinasa
dc.relation.publishversionhttps://academic.oup.com/ckj/article/14/2/543/5709132
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Roca N] Servicio de Nefrología Pediátrica, Consorci Hospitalari de Vic, Barcelona, Spain. Universitat de Vic, Barcelona, Spain. [Jatem E, Martín ML, Molina M, Martínez C] Servicio de Nefrología, Hospital Universitario Arnau de Vilanova, Lleida, Spain. Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain. [Muñoz M] Servei de Nefrologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33623677
dc.identifier.wos000642298900011
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/CP18%2F00116
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record